These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3833531)

  • 21. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term growth hormone responses to nonspecific hypothalamic hormones in acromegalic patients.
    Watanabe M; Kuwayama A; Nakane T; Kanie N; Kato T; Takahashi T; Kageyama N
    Surg Neurol; 1985 Oct; 24(4):449-56. PubMed ID: 4035555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.
    Tsuchiya H; Onishi T; Mogami H; Iida M
    Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
    Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian variation of basal plasma growth hormone in man.
    Drobny EC; Amburn K; Baumann G
    J Clin Endocrinol Metab; 1983 Sep; 57(3):524-8. PubMed ID: 6348063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of trans-sphenoidal surgery for the treatment of acromegaly].
    Pumar A; Santos C; García-Luna PP; Acosta D; Pereira JL; Gavilán I; Leal-Cerro A; Astorga R
    Rev Clin Esp; 1991 Feb; 188(2):76-80. PubMed ID: 2041904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acromegaly: reassessment of the long-term therapeutic effectiveness of transsphenoidal pituitary surgery.
    Schuster LD; Bantle JP; Oppenheimer JH; Seljeskog EL
    Ann Intern Med; 1981 Aug; 95(2):172-4. PubMed ID: 7258865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
    Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up.
    van't Verlaat JW; Nortier JW; Hendriks MJ; Bosma NJ; Graamans K; Lubsen H; Vasen HF; Thijssen JH; Croughs RJ
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):154-8. PubMed ID: 3381631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients.
    Ross DA; Wilson CB
    J Neurosurg; 1988 Jun; 68(6):854-67. PubMed ID: 3373281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
    Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
    J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations.
    Zada G; Cavallo LM; Esposito F; Fernandez-Jimenez JC; Tasiou A; De Angelis M; Cafiero T; Cappabianca P; Laws ER
    Neurosurg Focus; 2010 Oct; 29(4):E8. PubMed ID: 20887133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery.
    Roelfsema F; van der Heide D; Lowry PJ; van Dulken H; Schröder-van der Elst J
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):51-9. PubMed ID: 2844444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional treatment of acromegaly by transsphenoidal microsurgery.
    García-Uría J; del Pozo JM; Bravo G
    J Neurosurg; 1978 Jul; 49(1):36-40. PubMed ID: 660266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
    De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid growth hormone measurement during transsphenoidal surgery: analysis of 252 acromegalic patients.
    Otani R; Fukuhara N; Ochi T; Oyama K; Yamada S
    Neurol Med Chir (Tokyo); 2012; 52(8):558-62. PubMed ID: 22976138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.